151 related articles for article (PubMed ID: 23342677)
21. Prolonged trastuzumab therapy in a patient with recurrent breast cancer and anthracycline-induced cardiac failure.
Walji N; Bhatt L; Dhallu S; Fernando IN
Breast; 2008 Aug; 17(4):423-5. PubMed ID: 18479923
[TBL] [Abstract][Full Text] [Related]
22. Cardiac toxicity of trastuzumab in metastatic breast cancer patients previously treated with high-dose chemotherapy: a retrospective study.
Bengala C; Zamagni C; Pedrazzoli P; Matteucci P; Ballestrero A; Da Prada G; Martino M; Rosti G; Danova M; Bregni M; Jovic G; Guarneri V; Maur M; Conte PF;
Br J Cancer; 2006 Apr; 94(7):1016-20. PubMed ID: 16570045
[TBL] [Abstract][Full Text] [Related]
23. Is there more for us to learn from oncology?: Examining the implications of anthracycline effects on the young heart.
Sawyer DB
Circulation; 2010 Feb; 121(5):623-5. PubMed ID: 20100976
[No Abstract] [Full Text] [Related]
24. Cardiac risks in multimodal breast cancer treatment.
Budach W
Strahlenther Onkol; 2007 Dec; 183 Spec No 2():9-10. PubMed ID: 18166997
[No Abstract] [Full Text] [Related]
25. Cardiac testing to manage cardiovascular risk in cancer patients.
Davis M; Witteles RM
Semin Oncol; 2013 Apr; 40(2):147-55. PubMed ID: 23540740
[TBL] [Abstract][Full Text] [Related]
26. Cardiotoxicity associated with trastuzumab (Herceptin) therapy in the treatment of metastatic breast cancer.
Suter TM; Cook-Bruns N; Barton C
Breast; 2004 Jun; 13(3):173-83. PubMed ID: 15177418
[TBL] [Abstract][Full Text] [Related]
27. Adjuvant therapy for HER2 positive breast cancer: are anthracyclines still necessary?
Castrellon AB; Glück S
Clin Adv Hematol Oncol; 2008 Sep; 6(9):666-72. PubMed ID: 18827789
[TBL] [Abstract][Full Text] [Related]
28. Reversibility of trastuzumab cardiotoxicity: is the concept alive and well?
Ewer MS; Tan-Chiu E
J Clin Oncol; 2007 Dec; 25(34):5532-3; author reply 5533-4. PubMed ID: 18048835
[No Abstract] [Full Text] [Related]
29. Update on administration of adjuvant trastuzumab.
McArthur HL
Clin Adv Hematol Oncol; 2010 May; 8(5):321-2, 375. PubMed ID: 20551890
[No Abstract] [Full Text] [Related]
30. Neoadjuvant trastuzumab for breast cancer. Better to stick with proven treatments.
Prescrire Int; 2013 Feb; 22(135):39. PubMed ID: 23444499
[TBL] [Abstract][Full Text] [Related]
31. Chemotherapy-induced cardiotoxicity in women.
Dempsey KS
Crit Care Nurs Clin North Am; 2008 Sep; 20(3):343-50. PubMed ID: 18644518
[TBL] [Abstract][Full Text] [Related]
32. Trastuzumab cardiac side effects: only time will tell.
Levine MN
J Clin Oncol; 2005 Nov; 23(31):7775-6. PubMed ID: 16258081
[No Abstract] [Full Text] [Related]
33. Re: Therapy Insight: anthracyclines and trastuzumab--the optimal management of cardiotoxic side effects.
Magné N; Chargari C
Nat Clin Pract Oncol; 2008 Nov; 5(11):E1. PubMed ID: 18957967
[No Abstract] [Full Text] [Related]
34. Never use anthracyclines with trastuzumab: it is time to reconsider the taboo.
Gianni L
Breast Cancer Res Treat; 2009 Oct; 117(3):599-601. PubMed ID: 19387827
[No Abstract] [Full Text] [Related]
35. Desensitization to chemotherapeutic agents.
Lieberman P; Castells M
J Allergy Clin Immunol Pract; 2014; 2(1):116-7. PubMed ID: 24565784
[No Abstract] [Full Text] [Related]
36. Commentary: anthracyclines in early-stage breast cancer: is it the end of an era?
Pritchard KI
Oncologist; 2009 Oct; 14(10):959-62. PubMed ID: 19819915
[No Abstract] [Full Text] [Related]
37. Ongoing debate: anthracyclines and adjuvant treatment of human epidermal growth factor receptor 2-positive breast cancer.
Mahesh S
J Clin Oncol; 2012 Dec; 30(35):4445-6; author reply 4446. PubMed ID: 23071231
[No Abstract] [Full Text] [Related]
38. Troponin I provides insight into cardiotoxicity and the anthracycline-trastuzumab interaction.
Ewer MS; Ewer SM
J Clin Oncol; 2010 Sep; 28(25):3901-4. PubMed ID: 20679626
[No Abstract] [Full Text] [Related]
39. Incidence of heart failure or cardiomyopathy after adjuvant trastuzumab therapy for breast cancer.
Chen J; Long JB; Hurria A; Owusu C; Steingart RM; Gross CP
J Am Coll Cardiol; 2012 Dec; 60(24):2504-12. PubMed ID: 23158536
[TBL] [Abstract][Full Text] [Related]
40. Trastuzumab cardiotoxicity in patients with breast cancer.
Freitas AF; Rassi S
Arq Bras Cardiol; 2014 Feb; 102(2):200. PubMed ID: 24676377
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]